Zurich Cantonal Bank
SRPT icon

Zurich Cantonal Bank’s Sarepta Therapeutics SRPT Stock Holding History

Zurich Cantonal Bank’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$651K Hold
36,221
– – ﹤0.01% 1799
2026
Q1 		$788K Buy
+36,221
New +$701K ﹤0.01% 1569
2025
Q4 		– Sell
-27,500
Closed -$580K – 3390
2025
Q3 		$530K Buy
27,500
+1,559
+6% +$27.8K ﹤0.01% 1707
2025
Q2 		$444K Buy
25,941
+2,229
+9% +$95.1K ﹤0.01% 1736
2025
Q1 		$1.51M Buy
23,712
+2,368
+11% +$249K ﹤0.01% 957
2024
Q4 		$2.6M Buy
21,344
+2,492
+13% +$305K 0.01% 757
2024
Q3 		$2.35M Buy
18,852
+557
+3% +$77K 0.01% 756
2024
Q2 		$2.89M Buy
18,295
+674
+4% +$86.6K 0.01% 663
2024
Q1 		$2.28M Buy
17,621
+245
+1% +$30K 0.01% 717
2023
Q4 		$1.68M Buy
17,376
+1,529
+10% +$147K 0.01% 805
2023
Q3 		$1.92M Buy
15,847
+2,364
+18% +$267K 0.01% 714
2023
Q2 		$1.54M Buy
13,483
+1,131
+9% +$146K 0.01% 781
2023
Q1 		$1.7M Buy
12,352
+356
+3% +$46.2K 0.01% 726
2022
Q4 		$1.55M Buy
11,996
+927
+8% +$107K 0.01% 735
2022
Q3 		$1.22M Buy
11,069
+305
+3% +$30.7K 0.01% 788
2022
Q2 		$807K Sell
10,764
-784
-7% -$57.7K ﹤0.01% 950
2022
Q1 		$902K Buy
11,548
+1,742
+18% +$133K ﹤0.01% 989
2021
Q4 		$883K Buy
9,806
+2,514
+34% +$215K ﹤0.01% 1062
2021
Q3 		$674K Hold
7,292
– – ﹤0.01% 1110
2021
Q2 		$567K Sell
7,292
-20,159
-73% -$1.53M ﹤0.01% 1156
2021
Q1 		$2.05M Buy
27,451
+1,838
+7% +$170K 0.01% 692
2020
Q4 		$4.37M Buy
25,613
+12,118
+90% +$1.8M 0.03% 532
2020
Q3 		$1.9M Buy
13,495
+3,793
+39% +$576K 0.01% 703
2020
Q2 		$1.56M Sell
9,702
-4,222
-30% -$575K 0.01% 705
2020
Q1 		$1.36M Buy
13,924
+917
+7% +$105K 0.01% 674
2019
Q4 		$1.68M Hold
13,007
– – 0.01% 712
2019
Q3 		$980K Buy
13,007
+9,073
+231% +$1.07M 0.01% 800
2019
Q2 		$598K Hold
3,934
– – 0.01% 883
2019
Q1 		$469K Sell
3,934
-222
-5% -$28.5K ﹤0.01% 904
2018
Q4 		$454K Buy
4,156
+348
+9% +$43.5K ﹤0.01% 904
2018
Q3 		$615K Hold
3,808
– – 0.01% 879
2018
Q2 		$503K Buy
3,808
+360
+10% +$34K ﹤0.01% 905
2018
Q1 		$255K Hold
3,448
– – ﹤0.01% 1079
2017
Q4 		$192K Buy
3,448
+977
+40% +$51.8K ﹤0.01% 1207
2017
Q3 		$112K Buy
2,471
+895
+57% +$35.8K ﹤0.01% 1323
2017
Q2 		$53K Buy
1,576
+287
+22% +$9.35K ﹤0.01% 1726
2017
Q1 		$38K Hold
1,289
– – ﹤0.01% 1947
2016
Q4 		$35K Hold
1,289
– – ﹤0.01% 1950
2016
Q3 		$79K Buy
1,289
+226
+21% +$6.83K ﹤0.01% 1407
2016
Q2 		$20K Hold
1,063
– – ﹤0.01% 2115
2016
Q1 		$21K Hold
1,063
– – ﹤0.01% 2019
2015
Q4 		$41K Buy
1,063
+623
+142% +$20.2K ﹤0.01% 1552
2015
Q3 		$14K Buy
440
+217
+97% +$7.36K ﹤0.01% 1691
2015
Q2 		$7K Buy
+223
New +$4.56K ﹤0.01% 1654

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Zurich Cantonal Bank's SRPT Position: Q2 2026 in Review

Zurich Cantonal Bank held its Sarepta Therapeutics (SRPT) position steady in Q2 2026 at 36,221 shares worth $651K. The position accounts for ﹤0.01% of the portfolio, ranked #1799.

Zurich Cantonal Bank first reported a position in SRPT in Q2 2015 and has held it in 44 quarters since. The position peaked at $4.37M in Q4 2020. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Zurich Cantonal Bank held 36,221 shares of Sarepta Therapeutics worth $651K as of Q2 2026.
  • Zurich Cantonal Bank left its Sarepta Therapeutics share count unchanged in Q2 2026.
  • Sarepta Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1799 holding.
  • Zurich Cantonal Bank first reported a position in Sarepta Therapeutics in Q2 2015 and has held it in 44 quarters since.
  • Zurich Cantonal Bank's Sarepta Therapeutics position peaked at $4.37M in Q4 2020.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.